Switching Study From Warfarin to Rivaroxaban
clinical trial
Press Enter · cited answer in seconds
0 sources
Summary
Switching Study From Warfarin to Rivaroxaban is a clinical trial[1].
Key Facts
- Switching Study From Warfarin to Rivaroxaban is in the country of Germany[2].
- Switching Study From Warfarin to Rivaroxaban's instance of is recorded as clinical trial[3].
- Switching Study From Warfarin to Rivaroxaban's start time is recorded as +2008-11-30T00:00:00Z[4].
- Switching Study From Warfarin to Rivaroxaban's end time is recorded as +2009-11-30T00:00:00Z[5].
- Switching Study From Warfarin to Rivaroxaban's sponsor is recorded as Bayer[6].
- Switching Study From Warfarin to Rivaroxaban's sponsor is recorded as Johnson & Johnson Pharmaceutical Research and Development[7].
- Switching Study From Warfarin to Rivaroxaban's main subject is recorded as thrombosis[8].
- Switching Study From Warfarin to Rivaroxaban's number of participants is recorded as {'unit': '1', 'amount': '+96'}[9].
- Switching Study From Warfarin to Rivaroxaban's title is recorded as Randomized, Placebo-controlled, Parallel-group Study in Healthy Male Subjects to Investigate the Pharmacodynamics During the Switching Procedure From Warfarin to Rivaroxaban[10].
- Switching Study From Warfarin to Rivaroxaban's uses is recorded as partial thromboplastin time[11].
- Switching Study From Warfarin to Rivaroxaban's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[12].
- Switching Study From Warfarin to Rivaroxaban's ClinicalTrials.gov ID is recorded as NCT01507051[13].
- Switching Study From Warfarin to Rivaroxaban's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+45'}[14].
- Switching Study From Warfarin to Rivaroxaban's research intervention is recorded as (E)-phytonadione[15].
- Switching Study From Warfarin to Rivaroxaban's research intervention is recorded as rivaroxaban diol[16].
- Switching Study From Warfarin to Rivaroxaban's clinical trial phase is recorded as phase I clinical trial[17].
- Switching Study From Warfarin to Rivaroxaban's research subject recruitment status is recorded as completed[18].
- Switching Study From Warfarin to Rivaroxaban's study type is recorded as interventional study[19].